- Home
- AXGN vs MLTX Comparison
AXGN vs MLTX Comparison
Compare AXGN & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXGN | MLTX |
|---|---|---|
| Founded | N/A | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.1B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AXGN | MLTX |
|---|---|---|
| Price | $32.19 | $17.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $36.11 | $25.70 |
| AVG Volume (30 Days) | 737.2K | ★ 1.1M |
| Earning Date | 05-15-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $225,208,000.00 | N/A |
| Revenue This Year | $19.81 | N/A |
| Revenue Next Year | $16.31 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.21 | N/A |
| 52 Week Low | $9.22 | $5.95 |
| 52 Week High | $36.00 | $62.75 |
Technical Indicators
Market Signals| Indicator | AXGN | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.61 | 56.37 |
| Support Level | $29.13 | $17.00 |
| Resistance Level | $34.26 | $19.15 |
| Average True Range (ATR) | 1.59 | 0.88 |
| MACD | -0.15 | -0.05 |
| Stochastic Oscillator | 54.85 | 37.35 |
Price Performance
Historical ComparisonAbout AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.